Exploring Light-Sensitive Nanocarriers for Simultaneous Triggered Antibiotic Release and Disruption of Biofilms Upon Generation of Laser-Induced Vapor Nanobubbles.

biofilms diffusion barrier gold nanoparticles graphene quantum dots laser treatment liposomes triggered release vapor nanobubbles

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
01 May 2019
Historique:
received: 08 03 2019
revised: 03 04 2019
accepted: 15 04 2019
entrez: 5 5 2019
pubmed: 6 5 2019
medline: 6 5 2019
Statut: epublish

Résumé

Impaired penetration of antibiotics through bacterial biofilms is one of the reasons for failure of antimicrobial therapy. Hindered drug diffusion is caused on the one hand by interactions with the sticky biofilm matrix and on the other hand by the fact that bacterial cells are organized in densely packed clusters of cells. Binding interactions with the biofilm matrix can be avoided by encapsulating the antibiotics into nanocarriers, while interfering with the integrity of the dense cell clusters can enhance drug transport deep into the biofilm. Vapor nanobubbles (VNB), generated from laser irradiated nanoparticles, are a recently reported effective way to loosen up the biofilm structure in order to enhance drug transport and efficacy. In the present study, we explored if the disruptive force of VNB can be used simultaneously to interfere with the biofilm structure and trigger antibiotic release from light-responsive nanocarriers. The antibiotic tobramycin was incorporated in two types of light-responsive nanocarriers-liposomes functionalized with gold nanoparticles (Lip-AuNP) and graphene quantum dots (GQD)-and their efficacy was evaluated on

Identifiants

pubmed: 31052369
pii: pharmaceutics11050201
doi: 10.3390/pharmaceutics11050201
pmc: PMC6571820
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Fonds Wetenschappelijk Onderzoek
ID : 1500418N
Organisme : Light Activated Drug Delivery System (LADDS) project
ID : 4208/31/2015
Organisme : European Research Council
ID : 648124
Pays : International
Organisme : Agentschap voor Innovatie door Wetenschap en Technologie
ID : 141135
Organisme : University Ghent Special Research Fund/Concerted Research Actions
ID : 01G02215

Références

Appl Environ Microbiol. 2001 Dec;67(12):5608-13
pubmed: 11722913
Int J Pharm. 2006 Jan 13;307(2):244-50
pubmed: 16289986
J Antimicrob Chemother. 2008 Apr;61(4):859-68
pubmed: 18305202
J Microencapsul. 1991 Jan-Mar;8(1):53-61
pubmed: 1908898
Nanomedicine (Lond). 2009 Oct;4(7):813-45
pubmed: 19839816
Nat Rev Microbiol. 2010 Sep;8(9):623-33
pubmed: 20676145
Trends Microbiol. 2013 Sep;21(9):466-74
pubmed: 23827084
Acta Biomater. 2013 Dec;9(12):9243-57
pubmed: 23958782
PLoS One. 2013 Nov 14;8(11):e79220
pubmed: 24244452
Trends Microbiol. 2014 Jun;22(6):326-33
pubmed: 24598086
J Control Release. 2014 Sep 28;190:607-23
pubmed: 24794896
J Control Release. 2014 Dec 10;195:21-8
pubmed: 25125326
ACS Nano. 2015 Mar 24;9(3):2390-404
pubmed: 25661192
J Control Release. 2015 Apr 10;203:85-98
pubmed: 25701610
Nanoscale. 2015 Oct 14;7(38):15599-604
pubmed: 26372064
ACS Appl Mater Interfaces. 2016 Jan 13;8(1):20-5
pubmed: 26696468
Pharmaceutics. 2016 May 24;8(2):null
pubmed: 27231933
ACS Infect Dis. 2016 Apr 8;2(4):241-250
pubmed: 27441208
Nat Rev Microbiol. 2016 Aug 11;14(9):563-75
pubmed: 27510863
Nano Lett. 2016 Oct 12;16(10):5975-5986
pubmed: 27684962
J Control Release. 2017 Jan 10;245:137-146
pubmed: 27914995
J Control Release. 2017 Jan 28;246:164-173
pubmed: 27984105
Nat Rev Microbiol. 2017 Dec;15(12):740-755
pubmed: 28944770
ACS Appl Mater Interfaces. 2018 May 2;10(17):14426-14437
pubmed: 29651836
Nat Commun. 2018 Oct 30;9(1):4518
pubmed: 30375378
ACS Appl Mater Interfaces. 2018 Dec 5;10(48):41098-41106
pubmed: 30376295
Nanomicro Lett. 2018;10(1):10
pubmed: 30393659
ACS Appl Mater Interfaces. 2019 Jan 23;11(3):2768-2781
pubmed: 30589254
Light Sci Appl. 2018 Aug 8;7:47
pubmed: 30839577

Auteurs

Eline Teirlinck (E)

Laboratory of General Biochemistry and Physical Pharmacy, University of Ghent, 9000 Ghent, Belgium. Eline.Teirlinck@UGent.be.
Centre for Nano- and Biophotonics, 9000 Ghent, Belgium. Eline.Teirlinck@UGent.be.

Alexandre Barras (A)

Univ. Lille, CNRS, Centrale Lille, ISEN, Univ. Valenciennes, UMR 8520-IEMN, 59000 Lille, France. alexandre.barras@univ-lille.fr.

Jing Liu (J)

Laboratory of General Biochemistry and Physical Pharmacy, University of Ghent, 9000 Ghent, Belgium. jingli.Liu@UGent.be.
Centre for Nano- and Biophotonics, 9000 Ghent, Belgium. jingli.Liu@UGent.be.

Juan C Fraire (JC)

Laboratory of General Biochemistry and Physical Pharmacy, University of Ghent, 9000 Ghent, Belgium. Juan.Fraire@UGent.be.
Centre for Nano- and Biophotonics, 9000 Ghent, Belgium. Juan.Fraire@UGent.be.

Tatu Lajunen (T)

Drug Research Program, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, 00790 Helsinki, Finland. tatu.lajunen@helsinki.fi.

Ranhua Xiong (R)

Laboratory of General Biochemistry and Physical Pharmacy, University of Ghent, 9000 Ghent, Belgium. Ranhua.Xiong@UGent.be.
Centre for Nano- and Biophotonics, 9000 Ghent, Belgium. Ranhua.Xiong@UGent.be.

Katrien Forier (K)

Laboratory of General Biochemistry and Physical Pharmacy, University of Ghent, 9000 Ghent, Belgium. Katrien.Forier@UGent.be.
Centre for Nano- and Biophotonics, 9000 Ghent, Belgium. Katrien.Forier@UGent.be.

Chengnan Li (C)

Univ. Lille, CNRS, Centrale Lille, ISEN, Univ. Valenciennes, UMR 8520-IEMN, 59000 Lille, France. neu_lcn@163.com.

Arto Urtti (A)

Drug Research Program, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, 00790 Helsinki, Finland. arto.urtti@helsinki.fi.
School of Pharmacy, University of Eastern Finland, Yliopistonranta 1, 70211 Kuopio, Finland. arto.urtti@helsinki.fi.
Laboratory of Biohybrid Technologies, Institute of Chemistry, St. Petersburg State University, Universitetskii pr. 26, Peterhoff, St. 198504 Petersburg, Russia. arto.urtti@helsinki.fi.

Rabah Boukherroub (R)

Univ. Lille, CNRS, Centrale Lille, ISEN, Univ. Valenciennes, UMR 8520-IEMN, 59000 Lille, France. rabah.boukherroub@univ-lille.fr.

Sabine Szunerits (S)

Univ. Lille, CNRS, Centrale Lille, ISEN, Univ. Valenciennes, UMR 8520-IEMN, 59000 Lille, France. Sabine.Szunerits@univ-lille1.fr.

Stefaan C De Smedt (SC)

Laboratory of General Biochemistry and Physical Pharmacy, University of Ghent, 9000 Ghent, Belgium. Stefaan.Desmedt@UGent.be.
Centre for Nano- and Biophotonics, 9000 Ghent, Belgium. Stefaan.Desmedt@UGent.be.

Tom Coenye (T)

Laboratory of Pharmaceutical Microbiology, University of Ghent, 9000 Ghent, Belgium. Tom.Coenye@UGent.be.

Kevin Braeckmans (K)

Laboratory of General Biochemistry and Physical Pharmacy, University of Ghent, 9000 Ghent, Belgium. Kevin.Braeckmans@UGent.be.
Centre for Nano- and Biophotonics, 9000 Ghent, Belgium. Kevin.Braeckmans@UGent.be.
Univ. Lille, CNRS, Centrale Lille, ISEN, Univ. Valenciennes, UMR 8520-IEMN, 59000 Lille, France. Kevin.Braeckmans@UGent.be.

Classifications MeSH